HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $63,000 | -99.8% | 11,060 | -99.6% | 0.01% | -99.7% |
| Q4 2021 | $26,781,000 | +8.9% | 2,933,351 | +27.5% | 1.56% | +7.3% |
| Q3 2021 | $24,600,000 | +8.0% | 2,301,179 | +56.8% | 1.46% | +11.0% |
| Q2 2021 | $22,778,000 | +302.9% | 1,467,675 | +204.7% | 1.31% | +151.1% |
| Q1 2020 | $5,654,000 | +376.3% | 481,608 | +853.7% | 0.52% | +508.1% |
| Q4 2019 | $1,187,000 | -71.7% | 50,500 | -77.8% | 0.09% | -77.3% |
| Q3 2019 | $4,200,000 | -63.4% | 227,002 | -63.2% | 0.38% | -64.0% |
| Q2 2019 | $11,474,000 | +100.9% | 617,185 | +164.1% | 1.05% | +91.6% |
| Q1 2019 | $5,710,000 | -38.8% | 233,651 | -35.0% | 0.55% | -52.7% |
| Q4 2018 | $9,331,000 | -0.3% | 359,713 | +21.7% | 1.16% | +39.3% |
| Q3 2018 | $9,356,000 | -15.6% | 295,589 | +3.6% | 0.83% | +18.0% |
| Q2 2018 | $11,081,000 | +1231.9% | 285,229 | +846.6% | 0.71% | +394.4% |
| Q1 2018 | $832,000 | – | 30,133 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |